SOURCE: E-18 Corporation

August 05, 2009 08:30 ET

Protectus Management Profile: John D. ("Jack") Olinger, Veteran Hospital Executive and Distinguished Business Leader, Serves as Chairman of the Board and Chief Intelligence Officer

MINNEAPOLIS, MN--(Marketwire - August 5, 2009) - E-18 Corp. (OTCBB: ETEN) today provided a management profile of John D. ("Jack") Olinger, Chairman and Chief Intelligence Officer of E-18 Corp. The Company currently operates through its wholly owned subsidiary SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices").

Mr. Olinger is a seasoned business executive with nearly thirty-five years in top management positions. After receiving his MBA (with Honors) in Marketing and Hospital Administration from Northwestern University, he served in various executive-level positions in Hospital Administration in Chicago and in Wausau, Wisconsin. Most recently, he was President of HammerBlow Towing Systems Corp, which was sold to its largest competitor for eight times its then current EBITDA. He was also President of the Nanik Division of Apogee Enterprises, a Fortune 500 company. Mr. Olinger is also a co-founder and Chairman of the Board of Integrity First Bank in Wausau, Wisconsin, and has served on numerous Boards of businesses, social organizations and charities.

"Jack Olinger is a distinguished business leader, and we are delighted to have him as a valued member of the Protectus Medical Devices team," said Dr. John Salstrom, President and CEO of the company. "Based on his extensive experience in the healthcare industry as a hospital executive, Jack's inside view of how hospitals work will be invaluable to the Company as we bring the Protectus Medical Hypodermic Safety Syringe to market. Additionally, his success and proven track record as a business leader will provide exceptional value to the Company."

More information about Protectus Medical Devices may be found at the Company's corporate website at

About E-18 Corp.

E-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices, develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at

Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of E-18 Corp. can be found in the filings of E-18 Corp. with the U.S. Securities and Exchange Commission.

Contact Information